📰 Mark Siedner News
Page 2 - Mark Siedner News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Siedner. Real-time updates on events, politics, business and more.
November 14, 2023
Paxlovid helps prevent severe COVID-19, but it also might significantly increase a person's risk of a rebound case, a new study confirms.
November 14, 2023
While US pharma Pfizer’s antiviral Paxlovid remains a lifesaving drug, a new study showed that one in five individuals experienced Covid rebound.
November 14, 2023
Covid-19 rebound, when the virus increases in the body after initially decreasing, affected just under 21 per cent of people after they took Paxlovid in a trial, compared with fewer than 2 per cent not on the treatment
November 14, 2023
According to a new study, one in five people who take Paxlovid to treat COVID-19 end up having a rebound infection.
November 14, 2023
Paxlovid helps prevent severe COVID-19, but it also might significantly increase a person's risk of a rebound case, a new study confirms.
November 14, 2023
At a glance: New study shows that viral rebound with Paxlovid is more common than previously believed. Clinicians should counsel patients about the possible risk of transmitting virus during rebound. A new study by Harvard Medical School researchers at Massachusetts General Hospital and Brigham and Women’s Hospital has found that one in five individuals […]
November 13, 2023
The study’s authors and outside experts emphasize that there is no question that Paxlovid is a useful drug that can prevent hospitalization.
November 13, 2023
Though antivirals are critical for reducing severe COVID-19 symptoms, researchers suggested that the medication may not always be needed for milder cases.
October 2, 2022
Scientists have spent an inordinate amount of time during the COVID pandemic sifting through sewage—an attempt to consult the so-called "oracle in the
August 17, 2022
Last week, the CDC announced that it was relaxing key areas of its COVID guidelines. Do these changes make sense?